Related Experiment Video
Updated: Jul 29, 2025
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Plasmacytoid bladder cancer: a rare case report.
Wajdi Benabdallah1, Mouna Ben Othmane1, Ines Ouahchi2
1Urology Department.
Annals of Medicine and Surgery (2012)
|May 25, 2023
Summary
Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare, aggressive cancer often diagnosed late. This case highlights its poor prognosis and challenges in treatment, emphasizing the need for further research.
Area of Science:
- Uro-oncology
- Pathology
- Medical Case Reports
Background:
- Plasmacytoid urothelial carcinoma (PUC) is a rare variant of bladder cancer.
- It is associated with late diagnosis and a poor prognosis.
- Limited treatment guidelines exist due to its rarity.
Purpose of the Study:
- To report a case of locally advanced PUC.
- To illustrate the challenges in managing this rare bladder cancer variant.
- To underscore the aggressive nature and poor outcomes associated with PUC.
Main Methods:
- Case presentation of a 71-year-old male with gross hematuria.
- Diagnostic workup included rectal examination and CT scan.
- Histopathological examination confirmed muscle-invasive PUC.
- Treatment decision involved palliative chemotherapy.
Main Results:
- The patient presented with locally advanced, muscle-invasive PUC.
- The tumor extended to the perivesical fat.
- Despite palliative chemotherapy, the patient died 6 weeks post-surgery.
- This case exemplifies the aggressive behavior and poor prognosis of PUC.
Conclusions:
- PUC of the bladder is characterized by high aggressiveness.
- Diagnosis typically occurs at an advanced stage.
- The prognosis for PUC is poor, necessitating further investigation into optimal treatment strategies.
